Features Screener Stocks Charts
Sign In Sign Up

Abbott India Limited Cash Flow Statement

NSE:ABBOTINDIA | PHARMACEUTICALS

Showing 2 of 10 years of data. Sign up free for 3 years, or upgrade for full access.

View Plans

Cash Flow Insights

Cash Conversion

0.54x

ABBOTINDIA's operating cash flow covered 54% of net income in FY 2025. Some earnings may be tied up in working capital.

Free Cash Flow

₹9.59B

ABBOTINDIA's free cash flow was ₹9.59B in FY 2025, down 17.6% from FY 2024.

Dividend Coverage

1.1x

ABBOTINDIA's free cash flow covered dividends 1.1x in FY 2025 but leaves limited surplus.

CapEx Intensity

5.2%

Capital expenditure was 5.2% of operating cash flow in FY 2025 for ABBOTINDIA, indicating a capital-light business.

2-year ABBOTINDIA cash flow snapshot

Hover the chart icon for YoY change.

FY 2024 - FY 2025
Item Chart 2024 2025
Net Income 16.18B 18.87B
Cash flow Operating Activities 12.13B 10.12B
Investments in PPE -483.30M -526.00M
Cash flow Investing Activities -4.16B 1.82B
Dividend Paid -6.91B -8.71B
Cash flow Financing Activities -7.45B -9.25B
Cash at beginning of period 2.40B 2.92B
Cash at end of period 2.92B 5.61B
Free Cash Flow 11.64B 9.59B

Values are shown in millions (M) and billions (B). All amounts are in Indian Rupees (₹).

Data from audited consolidated filings. For educational purposes only — not investment advice. Last update: Mar-2025